COPD Trial, Recruiting NCT06882265 Sponsor: University of Sao Paulo General Hospital Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT06882265
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with both COPD (a lung condition that blocks airflow) and ILD (a condition that causes scarring or inflammation in the lungs), confirmed by clinical assessment, imaging, or tissue testing, following recognised international guidelines
  • People aged 18 years or older
  • People whose lung condition has been stable — meaning no flare-ups or hospital stays related to their lung disease — for at least the past 6 weeks
  • People who are already on the best available medication for their condition, including oxygen therapy used at home over the long term
  • People who own a smartphone that works with the study's monitoring device
  • People who are willing to sign a consent form agreeing to take part in the study

Who may not be able to join:

  • People who have other lung diseases in addition to COPD and ILD
  • People who have had a heart attack in the four months before the study starts, or who have unstable chest pain, or a serious or poorly controlled heart condition (confirm with trial site for exact heart condition classifications)
  • People who receive a lung transplant during the course of the study
  • People who live outside the area covered by the study, or who plan to move out of the state during the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 55 11 98415-3234

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
10 November 2024
Est. completion
30 July 2025

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

Health-related quality of life (HRQOL): assessed using the EQ-5D-5L Questionnaire

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov